Trial Profile
Effects and comparisons of once & twice daily insulin's in combination with oral hypoglycaemic agents on glycaemic control, hypoglycaemia and weight in type 2 Diabetes.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2011
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin detemir (Primary) ; Insulin glargine (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 May 2011 New trial record